Novo expands diabetes research in China
September 16, 2010Research and Development China, Novo Nordisk, diabetes
Diabetes is at the core of Novo Nordisk’s latest investment in China, where the company plans to more than double …
Digital Pharma: Lilly aims to be social on its Lillypad
September 16, 2010Medical Communications Digital Pharma blog, Twitter, blog, lilly
Lilly has jumped feet first into the social media scene this week, launching a corporate blog and a Twitter account. …
AstraZeneca’s Brilinta delayed
September 16, 2010Sales and Marketing Brillinta, Effient, Plavix, clopidogrel
AstraZeneca’s blood thinning drug Brilinta faces an extra three month delay to its review by the FDA. The US regulator …
Representing medium-sized pharma
September 16, 2010Sales and Marketing European Medicines Group, UCB
UCB’s Matthew Speers is the new chairman of the European Medicines Group, which represents European-owned pharma companies in the UK. …
GSK’s leukaemia drug rejected by NICE
September 16, 2010Sales and Marketing Arzerra, GSK, NHS, NICE
GSK’s leukaemia treatment Arzerra has been rejected by NICE, which says the drug does not represent good value for the …
Gilenya approved in Russia, awaits FDA decision
September 16, 2010Sales and Marketing Cladribine, Gilena, MS
Novartis has won approval for its MS drug Gilenya in Russia but still awaits the FDA’s decision on its fate …
Pepscan and Tibotec sign peptides deal
September 15, 2010Research and Development, Sales and Marketing CLIPS, HIV, J&J, JJ, Pepscan, Tibotec
Pepscan Therapeutics, the biotech firm focusing on protein mimicry technology has signed a deal with Tibotec. Netherlands-based Pepscan will use …
FDA warns BMS over manufacturing plant in Puerto Rico
September 15, 2010Manufacturing and Production BMS, FDA, GMP, Puerto Rico
A plant operated by Bristol-Myers Squibb in Puerto Rico has been cited by the US Food and Drug Administration for …
New Commercial Realities – Part 1: Key drivers of the evolving pharmaceutical landscape
September 15, 2010Faced with a changing healthcare environment and the prospect of diminishing commercial returns, the pharmaceutical industry has recognised that traditional …
New Commercial Realities – Part 1: Key drivers of the evolving pharmaceutical landscape
September 15, 2010Faced with a changing healthcare environment and the prospect of diminishing commercial returns, the pharmaceutical industry has recognised that traditional …
New Commercial Realities – Part 1: Key drivers of the evolving pharmaceutical landscape
September 15, 2010Faced with a changing healthcare environment and the prospect of diminishing commercial returns, the pharmaceutical industry has recognised that traditional …
New Commercial Realities – Part 1: Key drivers of the evolving pharmaceutical landscape
September 15, 2010Faced with a changing healthcare environment and the prospect of diminishing commercial returns, the pharmaceutical industry has recognised that traditional …
Digital Pharma: Boehringer gets social with Facebook
September 14, 2010Medical Communications Boehringer, Digital Pharma blog, Facebook
Boehringer Ingelheim is looking for fans on Facebook and wants its employees to be thought of as “superheroes, only with …
Positive results for irritable bowel syndrome drug
September 14, 2010Research and Development Almirall, IBS, linaclotide
A new treatment for patients with irritable bowel syndrome with constipation has produced promising results in a phase III trial. …
iPhone app is download hit for Doctors.net.uk
September 14, 2010Medical Communications Doctors.net.uk, doctors, iphone, tala, tim ringrose
An app launched by Doctors.net.uk in response to a surge in the number of doctors signing up for iPhones, has …
Future of Roche diabetes trial uncertain
September 14, 2010Research and Development GLP-1, Roche, taspoglutide
Roche has admitted it does not know when phase III trials of the investigational type II diabetes drug taspoglutide will …
Growth slowdown predicted for pharma packaging
September 14, 2010Manufacturing and Production packaging, pharma packaging
New regulatory requirements in the US are driving growth in the country’s pharmaceutical packaging market, according to market research firm …
Novasep appoints new supervisory board chairman
September 14, 2010Manufacturing and Production Novasep, appointment, manufacturing and production
French contract manufacturing firm Novasep has appointed Bernard Dubois to its top management team. Most recently a consultant, Bernard formerly …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
